Literature DB >> 16095608

Identification of a universal VHH framework to graft non-canonical antigen-binding loops of camel single-domain antibodies.

Dirk Saerens1, Mireille Pellis, Remy Loris, Els Pardon, Mireille Dumoulin, André Matagne, Lode Wyns, Serge Muyldermans, Katja Conrath.   

Abstract

Camel single-domain antibody fragments (VHHs) are promising tools in numerous biotechnological and medical applications. However, some conditions under which antibodies are used are so demanding that they can be met by only the most robust VHHs. A universal framework offering the required properties for use in various applications (e.g. as intrabody, as probe in biosensors or on micro-arrays) is highly valuable and might be further implemented when employment of VHHs in human therapy is envisaged. We identified the VHH framework of cAbBCII10 as a potential candidate, useful for the exchange of antigen specificities by complementarity determining region (CDR) grafting. Due to the large number of CDR-H loop structures present on VHHs, this grafting technique was expected to be rather unpredictable. Nonetheless, the plasticity of the cAbBCII10 framework allows successful transfer of antigen specificity from donor VHHs onto its scaffold. The cAbBCII10 was chosen essentially for its high level of stability (47 kJmol(-1)), good expression level (5 mgl(-1) in E.coli) and its ability to be functional in the absence of the conserved disulfide bond. All five chimeras generated by grafting CDR-Hs, from donor VHHs belonging to subfamily 2 that encompass 75% of all antigen-specific VHHs, on the framework of cAbBCII10 were functional and generally had an increased thermodynamic stability. The grafting of CDR-H loops from VHHs belonging to other subfamilies resulted in chimeras of reduced antigen-binding capacity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16095608     DOI: 10.1016/j.jmb.2005.07.038

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  72 in total

1.  Fluorescent fusion protein knockout mediated by anti-GFP nanobody.

Authors:  Emmanuel Caussinus; Oguz Kanca; Markus Affolter
Journal:  Nat Struct Mol Biol       Date:  2011-12-11       Impact factor: 15.369

2.  Dual beneficial effect of interloop disulfide bond for single domain antibody fragments.

Authors:  Jochen Govaert; Mireille Pellis; Nick Deschacht; Cécile Vincke; Katja Conrath; Serge Muyldermans; Dirk Saerens
Journal:  J Biol Chem       Date:  2011-11-29       Impact factor: 5.157

Review 3.  Engineered antibody therapies to counteract mutant huntingtin and related toxic intracellular proteins.

Authors:  David C Butler; Julie A McLear; Anne Messer
Journal:  Prog Neurobiol       Date:  2011-11-18       Impact factor: 11.685

4.  Translational fusion and redirection to thylakoid lumen as strategies to improve the accumulation of a camelid antibody fragment in transplastomic tobacco.

Authors:  Ezequiel M Lentz; Lorena Garaicoechea; E Federico Alfano; Viviana Parreño; Andrés Wigdorovitz; Fernando F Bravo-Almonacid
Journal:  Planta       Date:  2012-04-24       Impact factor: 4.116

5.  Structural and thermodynamic analysis of the GFP:GFP-nanobody complex.

Authors:  Marta H Kubala; Oleksiy Kovtun; Kirill Alexandrov; Brett M Collins
Journal:  Protein Sci       Date:  2010-12       Impact factor: 6.725

6.  The role of intra-domain disulfide bonds in heat-induced irreversible denaturation of camelid single domain VHH antibodies.

Authors:  Yoko Akazawa-Ogawa; Koichi Uegaki; Yoshihisa Hagihara
Journal:  J Biochem       Date:  2015-08-19       Impact factor: 3.387

7.  Using microdialysis to analyse the passage of monovalent nanobodies through the blood-brain barrier.

Authors:  G Caljon; V Caveliers; T Lahoutte; B Stijlemans; G H Ghassabeh; J Van Den Abbeele; I Smolders; P De Baetselier; Y Michotte; S Muyldermans; S Magez; R Clinckers
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

8.  High affinity anti-inorganic material antibody generation by integrating graft and evolution technologies: potential of antibodies as biointerface molecules.

Authors:  Takamitsu Hattori; Mitsuo Umetsu; Takeshi Nakanishi; Takanari Togashi; Nozomi Yokoo; Hiroya Abe; Satoshi Ohara; Tadafumi Adschiri; Izumi Kumagai
Journal:  J Biol Chem       Date:  2009-12-31       Impact factor: 5.157

9.  High-level expression of Camelid nanobodies in Nicotiana benthamiana.

Authors:  Yi-Hui Audrey Teh; Tony A Kavanagh
Journal:  Transgenic Res       Date:  2009-10-28       Impact factor: 2.788

10.  An anti-hapten camelid antibody reveals a cryptic binding site with significant energetic contributions from a nonhypervariable loop.

Authors:  Sean W Fanning; James R Horn
Journal:  Protein Sci       Date:  2011-05-23       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.